Lee & Man Chemical Company Limited (HKG:0746)
4.980
+0.050 (1.01%)
Apr 29, 2026, 4:08 PM HKT
HKG:0746 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,755 | 3,951 | 4,051 | 5,867 | 5,186 | Upgrade
|
| Revenue Growth (YoY) | -4.96% | -2.46% | -30.96% | 13.13% | 67.31% | Upgrade
|
| Cost of Revenue | 2,460 | 2,787 | 2,988 | 3,743 | 2,847 | Upgrade
|
| Gross Profit | 1,295 | 1,164 | 1,062 | 2,124 | 2,339 | Upgrade
|
| Selling, General & Admin | 456.11 | 477.74 | 468.13 | 531.3 | 532.48 | Upgrade
|
| Research & Development | 169.03 | 135.8 | 120.75 | 204.01 | 230.89 | Upgrade
|
| Operating Expenses | 625.14 | 613.54 | 588.88 | 735.3 | 763.37 | Upgrade
|
| Operating Income | 669.65 | 550.51 | 473.29 | 1,388 | 1,576 | Upgrade
|
| Interest Expense | -17.3 | -21.9 | -39.28 | -38.66 | -47.62 | Upgrade
|
| Interest & Investment Income | 6.41 | 4.59 | 4.54 | 5.9 | 4.79 | Upgrade
|
| Earnings From Equity Investments | 5.26 | 3.69 | 0.54 | 0.31 | -1.25 | Upgrade
|
| Currency Exchange Gain (Loss) | -11.94 | 2.35 | -6.98 | -21.01 | 23.25 | Upgrade
|
| Other Non Operating Income (Expenses) | 61.08 | 59.4 | 73.3 | 60.95 | 61.15 | Upgrade
|
| EBT Excluding Unusual Items | 713.16 | 598.64 | 505.41 | 1,396 | 1,616 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 5.17 | -3.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.36 | -2.44 | -2.67 | -2.79 | -1.7 | Upgrade
|
| Asset Writedown | -5.5 | - | -8.84 | - | - | Upgrade
|
| Pretax Income | 706.31 | 596.2 | 493.9 | 1,398 | 1,611 | Upgrade
|
| Income Tax Expense | 148.05 | 113.91 | 93.23 | 241.34 | 323.07 | Upgrade
|
| Earnings From Continuing Operations | 558.26 | 482.28 | 400.67 | 1,157 | 1,288 | Upgrade
|
| Net Income | 558.26 | 482.28 | 400.67 | 1,157 | 1,288 | Upgrade
|
| Net Income to Common | 558.26 | 482.28 | 400.67 | 1,157 | 1,288 | Upgrade
|
| Net Income Growth | 15.75% | 20.37% | -65.36% | -10.19% | 156.26% | Upgrade
|
| Shares Outstanding (Basic) | 825 | 825 | 825 | 825 | 825 | Upgrade
|
| Shares Outstanding (Diluted) | 838 | 825 | 838 | 861 | 854 | Upgrade
|
| Shares Change (YoY) | 1.58% | -1.58% | -2.62% | 0.85% | 3.47% | Upgrade
|
| EPS (Basic) | 0.68 | 0.58 | 0.49 | 1.40 | 1.56 | Upgrade
|
| EPS (Diluted) | 0.67 | 0.58 | 0.48 | 1.34 | 1.51 | Upgrade
|
| EPS Growth | 13.93% | 22.30% | -64.44% | -10.93% | 147.78% | Upgrade
|
| Free Cash Flow | 563.53 | 291.28 | 208.35 | 988.84 | 806.91 | Upgrade
|
| Free Cash Flow Per Share | 0.67 | 0.35 | 0.25 | 1.15 | 0.94 | Upgrade
|
| Dividend Per Share | 0.335 | 0.290 | 0.190 | 0.550 | 0.580 | Upgrade
|
| Dividend Growth | 15.52% | 52.63% | -65.45% | -5.17% | 141.67% | Upgrade
|
| Gross Margin | 34.48% | 29.46% | 26.22% | 36.19% | 45.10% | Upgrade
|
| Operating Margin | 17.84% | 13.93% | 11.68% | 23.66% | 30.38% | Upgrade
|
| Profit Margin | 14.87% | 12.21% | 9.89% | 19.72% | 24.84% | Upgrade
|
| Free Cash Flow Margin | 15.01% | 7.37% | 5.14% | 16.85% | 15.56% | Upgrade
|
| EBITDA | 753.48 | 623.64 | 531.94 | 1,460 | 1,628 | Upgrade
|
| EBITDA Margin | 20.07% | 15.78% | 13.13% | 24.89% | 31.38% | Upgrade
|
| D&A For EBITDA | 83.83 | 73.13 | 58.66 | 71.98 | 52.02 | Upgrade
|
| EBIT | 669.65 | 550.51 | 473.29 | 1,388 | 1,576 | Upgrade
|
| EBIT Margin | 17.84% | 13.93% | 11.68% | 23.66% | 30.38% | Upgrade
|
| Effective Tax Rate | 20.96% | 19.11% | 18.88% | 17.26% | 20.05% | Upgrade
|
| Revenue as Reported | - | - | 4,051 | 5,867 | 5,186 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.